c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Opaleye management, a 10% owner, buys $123,819 of Grace Therapeutics stock
Investing.com | Oct 6, 2026 2:46 AM EDT
Read original article